Nexalin technology announces positive results of clinical study validating its gen-2 tacs device for reducing pain among veterans with mild traumatic brain injury at university of california, san diego

Collaborative study involving the va and ucsd achieved statistically significant decrease in pcs and ptsd symptoms versus control group

NXL Ratings Summary

NXL Quant Ranking